Skip to main content

aTYR PHARMA INC

ATYR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001339970

No open-market purchases or sales by aTYR PHARMA INC insiders were filed in the last 90 days; 89 institutions reported holding it in 13F filings for Q2 2026, worth $23.2M in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in aTYR PHARMA INC as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
47
+6 vs. Q3 2021
Shares held
20.6M
+1.73M (+9.2%) vs. Q3 2021
Total value
$153.5M
−$17.4M (−10.2%) vs. Q3 2021
New holders
17
10 more added
Sold out
11
12 more reduced

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ATYR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 47 institutions
Q1 2021: 25 institutionsQ2 2021: 29 institutionsQ3 2021: 42 institutionsQ4 2021: 47 institutionsQ1 2022: 41 institutionsQ2 2022: 36 institutionsQ3 2022: 33 institutionsQ4 2022: 36 institutionsQ1 2023: 37 institutionsQ2 2023: 41 institutionsQ3 2023: 41 institutionsQ4 2023: 46 institutionsQ1 2024: 56 institutionsQ2 2024: 47 institutionsQ3 2024: 56 institutionsQ4 2024: 77 institutionsQ1 2025: 87 institutionsQ2 2025: 110 institutionsQ3 2025: 103 institutionsQ4 2025: 84 institutionsQ1 2026: 111 institutionsQ2 2026: 89 institutions
Value heldQ4 2021: $153.5M
Q1 2021: $26.3MQ2 2021: $33.8MQ3 2021: $172.1MQ4 2021: $153.5MQ1 2022: $105.0MQ2 2022: $53.1MQ3 2022: $57.2MQ4 2022: $40.2MQ1 2023: $72.8MQ2 2023: $77.0MQ3 2023: $58.7MQ4 2023: $58.1MQ1 2024: $81.5MQ2 2024: $75.1MQ3 2024: $84.3MQ4 2024: $198.6MQ1 2025: $186.5MQ2 2025: $336.5MQ3 2025: $43.9MQ4 2025: $42.1MQ1 2026: $43.7MQ2 2026: $23.2M
Institutions holding ATYR and their total value by quarter
QuarterHoldersValue
Q2 202689$23.2M
Q1 2026111$43.7M
Q4 202584$42.1M
Q3 2025103$43.9M
Q2 2025110$336.5M
Q1 202587$186.5M
Q4 202477$198.6M
Q3 202456$84.3M
Q2 202447$75.1M
Q1 202456$81.5M
Q4 202346$58.1M
Q3 202341$58.7M
Q2 202341$77.0M
Q1 202337$72.8M
Q4 202236$40.2M
Q3 202233$57.2M
Q2 202236$53.1M
Q1 202241$105.0M
Q4 202147$153.5M
Q3 202142$172.1M
Q2 202129$33.8M
Q1 202125$26.3M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding aTYR PHARMA INC; share changes are against Q3 2021.

Institutions holding ATYR in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Federated Hermes, Inc.5,222,250$39.0M0.07%00.0%Unchanged
FMR LLC4,168,601$31.1M0.00%+105,308+2.6%Added
VR Adviser, LLC1,565,000$11.7M1.60%00.0%Unchanged
Tikvah Management LLC1,225,833$9.16M2.55%+1,225,833New
Tang Capital Management LLC1,113,453$8.32M1.67%00.0%Unchanged
Vanguard Group Inc1,113,191$8.31M0.00%+206,450+22.8%Added
Deep Track Capital, LP1,100,000$8.22M0.61%+1,100,000New
Alyeska Investment Group, L.P.674,975$5.04M0.06%−413,689−38.0%Reduced
Baker Bros. Advisors LP625,000$4.67M0.02%00.0%Unchanged
Stonepine Capital Management, LLC525,531$3.93M1.80%+114,996+28.0%Added
Two Sigma Investments, LP486,993$3.64M0.01%−54,728−10.1%Reduced
Two Sigma Advisers, LP387,352$2.89M0.01%−95,098−19.7%Reduced
BlackRock Inc.275,379$2.06M0.00%+58,367+26.9%Added
EAM Investors, LLC252,280$1.89M0.31%−7,511−2.9%Reduced
Marshall Wace, LLP250,396$1.87M0.00%+207,390+482.2%Added
Geode Capital Management, LLC231,499$1.73M0.00%+101,217+77.7%Added
Dimensional Fund Advisors LP226,712$1.69M0.00%+2,433+1.1%Added
Citadel Advisors LLC193,494$1.45M0.00%−6,921−3.5%Reduced
Telemetry Investments, L.L.C.176,782$1.32M1.73%+11,464+6.9%Added
EAM Global Investors LLC152,792$1.14M0.20%00.0%Unchanged
Renaissance Technologies LLC127,155$950.0K0.00%−52,500−29.2%Reduced
Gsa Capital Partners LLP58,791$439.0K0.06%+58,791New
State Street Corp55,999$418.0K0.00%00.0%Unchanged
Northern Trust Corp44,406$332.0K0.00%+19,733+80.0%Added
Ensign Peak Advisors, Inc37,884$283.0K0.00%00.0%Unchanged
Ikarian Capital, LLC35,048$262.0K0.07%−527,198−93.8%Reduced
Raymond James & Associates24,584$184.0K0.00%+24,584New
Nan Fung Group Holdings Ltd23,500$176.0K0.05%+23,500New
Morgan Stanley20,465$153.0K0.00%+20,465New
Millennium Management LLC19,656$147.0K0.00%−4,312−18.0%Reduced
Goldman Sachs Group Inc18,512$138.0K0.00%+18,512New
Trexquant Investment LP18,106$135.0K0.01%+18,106New
Cubist Systematic Strategies, LLC16,900$126.0K0.00%−34,427−67.1%Reduced
Ameriprise Financial Inc16,700$125.0K0.00%+16,700New
Jump Financial, LLC16,100$120.0K0.01%+16,100New
Blueshift Asset Management, LLC12,729$95.0K0.01%+12,729New
Tocqueville Asset Management L.P.12,150$91.0K0.00%−2,700−18.2%Reduced
Qube Research & Technologies Ltd11,665$87.0K0.00%+11,665New
Charles Schwab Investment Management Inc10,000$75.0K0.00%+10,000New
Cutler Group LP2,843$21.0K0.00%−12,681−81.7%Reduced
Wells Fargo & Company1,659$12.0K0.00%+71+4.5%Added
UBS Group AG1,132$8.00K0.00%+1,132New
Royal Bank of Canada500$4.00K0.00%+500New
PFS Partners, LLC406$3.03K0.00%+406New
RE Dickinson Investment Advisors, LLC300$2.00K0.00%+300New
Charter Oak Capital Management, LLC150$1.00K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)25$00.00%−656−96.3%Reduced
Virtu Financial LLC0$00.00%−143,677−100.0%Sold out
Jane Street Group, LLC0$00.00%−136,901−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−81,781−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−56,329−100.0%Sold out
Price T Rowe Associates Inc0$00.00%−12,024−100.0%Sold out
Sheaff Brock Investment Advisors, LLC0$00.00%−11,000−100.0%Sold out
Group One Trading, L.P.0$00.00%−2,022−100.0%Sold out
Bank of America Corp0$00.00%−382−100.0%Sold out
Carmichael Hill & Associates, Inc.0$00.00%−300−100.0%Sold out
Ironwood Financial, llc0$00.00%−50−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−1−100.0%Sold out
Polaris Venture Management Co. V, L.L.C.––––Not filed